Cardiovascular Risk Recruiting Phase 4 Trials for Sulfasalazine (DB00795)

Also known as: Cardiovascular Risk Factors / Cardiovascular Risk Factor / Cardiovascular Disease (CVD) Risk Factors / Cardiovascular Disease Risk Factors / Risk Factors Cardiovascular Disease / Cardiovascular Disease Risk / Cardiovascular Diseases Risk / Cardiovascular (CV) Risk / Cardiovascular Risks

IndicationStatusPhase
DBCOND0039927 (Cardiovascular Risk)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03254589Methotrexate, Blood Pressure and Arterial Function in Rheumatoid ArthritisTreatment